Cargando…
Successful Treatment of a Patient with Brentuximab Vedotin-Refractory ALK-Negative Anaplastic Large Cell Lymphoma with Romidepsin
We present the case of a 78-year-old male patient who was diagnosed with anaplastic lymphoma kinase (ALK)-negative, CC chemokine receptor 4 (CCR4)-negative, and CD30-positive anaplastic large cell lymphoma (ALCL). The patient had a past medical history of adult T-cell leukemia/lymphoma and colon can...
Autores principales: | Jo, Tatsuro, Sakai, Takahiro, Matsuzaka, Kaori, Shioya, Haruna, Tominaga, Hiroo, Kaneko, Yohei, Hayashi, Shizuka, Matsuo, Masatoshi, Taguchi, Jun, Abe, Kuniko, Shigematsu, Kazuto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772834/ https://www.ncbi.nlm.nih.gov/pubmed/33442363 http://dx.doi.org/10.1159/000511111 |
Ejemplares similares
-
Induction of Effector and Memory Cellular Immunity in a Patient with Long-Term Complete Molecular Response to Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
por: Jo, Tatsuro, et al.
Publicado: (2020) -
Elevation of Memory Cytotoxic T Lymphocytes, Including Human T Lymphotropic Virus Type 1 Tax-Specific and Hepatitis Virus Type C-Specific Cytotoxic T Lymphocytes, in a Patient with Adult T-Cell Leukemia/Lymphoma and Hepatocellular Carcinoma
por: Jo, Tatsuro, et al.
Publicado: (2020) -
Brentuximab Vedotin in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma
por: Tsang, Vivian
Publicado: (2012) -
Brentuximab vedotin use in pediatric anaplastic large cell lymphoma
por: Agrusa, Jennifer E., et al.
Publicado: (2023) -
Brentuximab Vedotin
Publicado: (2012)